Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
PrevABR
Vancouver, British Columbia, Canada
- Ownership
- Private
- Development stage
- Other
01
Overview
PreveCeutical has completed multiple pre-clinical research programs including BSV Nature Identical™ Peptide Program, Sol-Gel Cannabinoid Delivery Program, Dual Gene Therapy Program, and Non-Addictive Analgesic Program, with patent filings for pain management peptides showing potency comparable to morphine in vivo[1].
- Therapeutic areas
- OncologyEndocrinologyNeurologyInfectious Diseases
- Modalities
- PeptidesGene therapySol-Gel delivery
- Industry
- Biotech
02
Partnerships
UniQuest Pty Limited (University of Queensland)QIMR Berghofer Medical Research InstituteMurdoch UniversityAsterion Cannabis Inc.
Beyond the preview
Go deeper on PrevABR.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on PrevABR.